Wednesday, 29 August 2018

Reuters Health Report: Novartis says glaucoma stent setback will not derail Alcon spin-off

Reuters.com Newsletter

Novartis says glaucoma stent setback will not derail Alcon spin-off

Novartis' eye care unit Alcon is withdrawing a surgical stent for glaucoma patients after clinical data showed it may damage the eye, but the Swiss drugmaker said the move would not affect plans to spin off the unit next year.

China says can't rule out new African swine fever outbreaks

China's agriculture ministry said on Wednesday it cannot rule out the possibility of new African swine fever outbreaks as concerns grow over the deadly disease's spread in the world's largest hog herd.

Indian panel wants Johnson & Johnson to pay compensation over recalled implants

A government panel has recommended that Johnson & Johnson (J&J) pay compensation of at least $28,500 to each Indian patient who suffered from artificial hip implants the U.S. healthcare firm recalled eight years ago.

Dental care before cancer surgery might be good idea

(Reuters Health) - Patients undergoing major cancer surgery might reduce their risk of complications by seeing a dentist beforehand, a study from Japan suggests.

Emergent BioSolutions to buy Narcan maker Adapt Pharma

Emergent BioSolutions Inc said on Tuesday it would buy privately held Adapt Pharma, beefing up its portfolio with Narcan, the only FDA approved needle-free emergency opioid overdose treatment.

Few heavy drinkers get drugs to help curb alcohol use

(Reuters Health) - Less than one in 10 people with alcohol use disorders get prescribed medications that help people drink less and avoid binges, a U.S. study suggests.

Exclusive: Sterilization firm Sotera Health explores sale for nearly $5 billion - sources

Sotera Health, a private-equity owned company that operates facilities that sterilize medical products and food, is exploring a potential sale worth as much as $5 billion including debt, people familiar with the matter told Reuters on Tuesday.

Anxiety, depression tied to higher risk of heart attack, stroke

(Reuters Health) - Adults with mood disorders like anxiety and depression may be more likely to have a heart attack or stroke than people without mental illness, a new study suggests.

Heart benefits of fish oil, aspirin questioned in diabetics

(Reuters Health) - A new large study of fish oil and aspirin in people with diabetes has found that the oil supplements don't prevent first-time heart attacks or strokes, yet aspirin does, although the benefit of aspirin therapy is canceled out by a higher risk of unwanted bleeding.

Children taking multiple medications at risk for severe reactions

(Reuters Health) - Nearly one in five American children use at least one prescription medication, and roughly one in 13 kids takes more than one prescription drug, according to a new study.

India's health ministry calls for halting sales of e-cigarettes, smoking devices

India's federal health ministry called on Tuesday for stopping the sale or import of electronic cigarettes and heat-not-burn tobacco devices that companies like Philip Morris International Inc were planning to launch in the country.

Related Videos

Netflix is at Venice Film Fest after Cannes snub

Bombshell report accuses Pope of covering up abuse

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS